Terms: = Head and neck cancer AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155
16 results:
1. Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.
Lee M; Morris LG
Oncotarget; 2024 Jan; 15():36-48. PubMed ID: 38275291
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
3. An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in head and neck Squamous Cell Carcinoma.
Bredel M; Kim H; Bonner JA
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362284
[TBL] [Abstract] [Full Text] [Related]
4. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.
Wang J; Ge J; Wang Y; Xiong F; Guo J; Jiang X; Zhang L; Deng X; Gong Z; Zhang S; Yan Q; He Y; Li X; Shi L; Guo C; Wang F; Li Z; Zhou M; Xiang B; Li Y; Xiong W; Zeng Z
Nat Commun; 2022 Feb; 13(1):866. PubMed ID: 35165282
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in cancer.
Carrot-Zhang J; Chambwe N; Damrauer JS; Knijnenburg TA; Robertson AG; Yau C; Zhou W; Berger AC; Huang KL; Newberg JY; Mashl RJ; Romanel A; Sayaman RW; Demichelis F; Felau I; Frampton GM; Han S; Hoadley KA; Kemal A; Laird PW; Lazar AJ; Le X; Oak N; Shen H; Wong CK; Zenklusen JC; Ziv E; ; Cherniack AD; Beroukhim R
Cancer Cell; 2020 May; 37(5):639-654.e6. PubMed ID: 32396860
[TBL] [Abstract] [Full Text] [Related]
7. Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas.
Krishnan A; Berthelet J; Renaud E; Rosigkeit S; Distler U; Stawiski E; Wang J; Modrusan Z; Fiedler M; Bienz M; Tenzer S; Schad A; Roth W; Thiede B; Seshagiri S; Musholt TJ; Rajalingam K
Nat Commun; 2020 Apr; 11(1):2056. PubMed ID: 32345963
[TBL] [Abstract] [Full Text] [Related]
8. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract] [Full Text] [Related]
9. Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition.
Shi C; Pan BQ; Shi F; Xie ZH; Jiang YY; Shang L; Zhang Y; Xu X; Cai Y; Hao JJ; Wang MR
Oncogene; 2018 Jun; 37(24):3260-3274. PubMed ID: 29551772
[TBL] [Abstract] [Full Text] [Related]
10. A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma.
Li XC; Wang MY; Yang M; Dai HJ; Zhang BF; Wang W; Chu XL; Wang X; Zheng H; Niu RF; Zhang W; Chen KX
Ann Oncol; 2018 Apr; 29(4):938-944. PubMed ID: 29351612
[TBL] [Abstract] [Full Text] [Related]
11. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
Oishi N; Kondo T; Ebina A; Sato Y; Akaishi J; Hino R; Yamamoto N; Mochizuki K; Nakazawa T; Yokomichi H; Ito K; Ishikawa Y; Katoh R
Mod Pathol; 2017 Nov; 30(11):1527-1537. PubMed ID: 28731042
[TBL] [Abstract] [Full Text] [Related]
12. Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma.
Zhou H; Kann MG; Mallory EK; Yang YH; Bugshan A; Binmadi NO; Basile JR
Neoplasia; 2017 Feb; 19(2):65-74. PubMed ID: 28038319
[TBL] [Abstract] [Full Text] [Related]
13. Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis.
Nakazato H; Takeshima H; Kishino T; Kubo E; Hattori N; Nakajima T; Yamashita S; Igaki H; Tachimori Y; Kuniyoshi Y; Ushijima T
PLoS One; 2016; 11(1):e0147372. PubMed ID: 26812616
[TBL] [Abstract] [Full Text] [Related]
14. Computational analysis of the mutations in BAP1, pbrm1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma.
Piva F; Giulietti M; Occhipinti G; Santoni M; Massari F; Sotte V; Iacovelli R; Burattini L; Santini D; Montironi R; Cascinu S; Principato G
Oncotarget; 2015 Oct; 6(31):32161-8. PubMed ID: 26452128
[TBL] [Abstract] [Full Text] [Related]
15. Genomic copy number alterations of primary and secondary metastasizing pleomorphic adenomas.
Mariano FV; Gondak Rde O; Martins AS; Coletta RD; Paes de Almeida O; Kowalski LP; Krepischi AC; Altemani A
Histopathology; 2015 Sep; 67(3):410-5. PubMed ID: 25600428
[TBL] [Abstract] [Full Text] [Related]
16. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
[TBL] [Abstract] [Full Text] [Related]
